SCWorx Corp. Annual Report - How They Did This Year

I’m putting together a plain-English guide to help you understand how SCWorx Corp. performed this year. My goal is to break down their financial filings so you can decide if this company fits your investment strategy.

1. What does this company do?

Think of SCWorx as a "data plumber" for hospitals. Large healthcare systems often use dozens of software platforms that don't communicate well, leading to messy data and expensive errors.

SCWorx provides a platform that cleans this data, creating a single, reliable source of information. They offer tools for contract management and supply chain analytics to help hospitals reduce "price variance"—the common problem where hospitals pay different prices for the exact same medical supplies across different departments. They operate on a subscription-based model, charging recurring fees for their data services.

2. Financial performance: The "Turnaround" struggle

As of late 2025, SCWorx is a "micro-cap" stock with a market value of approximately $2.7 million. The company is currently facing significant financial headwinds:

• Revenue: They brought in $2.88 million in 2025, a 4% decrease from the $2.99 million reported in 2024. This reflects the ongoing challenge of retaining existing clients and securing new ones.
• Profitability: The company is currently operating at a loss. They reported a $4.44 million loss in 2025, compared to a $1.14 million loss in 2024. High operating costs relative to their current revenue base are the primary drivers of these losses.
• The "Going Concern" Warning: Management has noted "substantial doubt" regarding the company's ability to continue as a going concern. With a $35 million accumulated deficit and limited cash reserves, the company is under significant pressure to stabilize its finances.

3. Major wins and challenges

The company’s business model faces two primary structural hurdles:

• Customer Concentration: In 2025, the vast majority of revenue was generated by a very small number of healthcare systems. Because the company relies on these few "big fish," the loss of even one contract would have a material impact on their financial health.
• Operational Scale: With a team of only 9 employees, SCWorx relies heavily on outside contractors for software development and maintenance. While this keeps overhead lower, it limits the company's ability to scale operations quickly and creates dependencies on third-party service quality.

4. Key risks to watch

• Dilution: Because the company is currently losing money, they often issue new shares to raise necessary operating cash. This reduces the ownership percentage of existing shareholders and can exert downward pressure on the stock price.
• Financing Roadblocks: Existing debt agreements place restrictions on the company’s ability to raise new capital without lender approval. This may force the company to accept unfavorable terms to maintain liquidity.
• Implementation Delays: Sales cycles for hospital software are long, typically taking 6 to 18 months to close. Even after a deal is signed, setup and integration delays mean there is a significant lag between winning a contract and receiving payment, which puts a strain on cash flow.

Investor Takeaway: SCWorx is currently in a high-risk phase. Their survival depends on their ability to grow revenue, secure additional funding, or drastically reduce costs. When evaluating this company, focus on whether they can stabilize their cash flow and move toward profitability, as the current "going concern" status indicates that the company is in a fragile financial position.